Literature DB >> 22305593

Imaging inflammatory breast cancer.

J-P Alunni1.   

Abstract

Carcinomatous mastitis is a severe form of breast cancer and its diagnosis is essentially clinical and histological. The first examination to perform is still mammography, not only to provide evidence supporting this diagnosis but also to search for a primary intramammary lesion and assess local/regional spread. It is essential to study the contralateral breast for bilaterality. Ultrasound also provides evidence supporting inflammation, but appears to be better for detecting masses and analysing lymph node areas. The role of MRI is debatable, both from a diagnostic point of view and for monitoring during treatment, and should be reserved for selected cases. An optimal, initial radiological assessment will enable the patient to be monitored during neoadjuvant chemotherapy.
Copyright © 2011 Éditions française de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22305593     DOI: 10.1016/j.diii.2011.12.003

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  4 in total

1.  Ultrasound elastography and magnetic resonance examinations are effective for the accurate diagnosis of mammary duct ectasia.

Authors:  Feixue Zhang; Dexin Yu; Mingming Guo; Qing Wang; Zhigang Yu; Fei Zhou; Meng Zhao; Feng Xue; Guangrui Shao
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  The use of ultrasonography and digital mammography in women under 40 years with symptomatic breast cancer: a 7-year Irish experience.

Authors:  C E Redmond; G M Healy; C F Murphy; A O'Doherty; A Foster
Journal:  Ir J Med Sci       Date:  2016-06-07       Impact factor: 1.568

3.  Breast Abscessed Cancer in Nonlactating Women in Tropical Environment: Radiological, Bacteriological, and Anatomopathological Features about 3 Cases.

Authors:  Mazamaesso Tchaou; Tchin Darre; Ayi Kossi Amavi; Kokou Kouliwa Kanassoua; Bidamin N'Timon; Lantam Sonhaye; Lama-Kegdigoma Agoda-Koussema; Komlavi Adjenou
Journal:  Case Rep Radiol       Date:  2017-08-27

4.  Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer.

Authors:  Ida Skarping; Daniel Förnvik; Hanna Sartor; Uffe Heide-Jørgensen; Sophia Zackrisson; Signe Borgquist
Journal:  BMC Cancer       Date:  2019-12-30       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.